Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics

Expert Review of Proteomics

Volumn 7, Issue 1, 2010, Pages 21-27

  Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

2D DIGE; Cancer; Genome Medicine Database of Japan Proteomics; Mass spectrometry

Indexed keywords

PROTEOME;

CANCER CENTER; CANCER REGISTRY; CANCER RESEARCH; GENOME; GENOMICS; JAPAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REFERENCE DATABASE; REVIEW; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

DATABASES, PROTEIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; JAPAN; NEOPLASM PROTEINS; NEOPLASMS; PROTEOME; PROTEOMICS;

EID: 77951625250     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.87     Document Type: Review

References (46)

1. Fukui T, Mori S, Hatooka S, Shinoda M, Mitsudomi T. Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers. J. Thorac. Cardiovasc. Surg. 136(5), 1343-1348 (2008).
2. Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Validation of staging systems for gastric cancer. Gastric Cancer 11(2), 111-118 (2008).
3. Merkel S, Bialecki D, Meyer T, Muller V, Papadopoulos T, Hohenberger W. Comparison of clinical risk scores predicting prognosis after resection of colorectal liver metastases. J. Surg. Oncol. 100(5), 349-357 (2009).
4. Choi SB, Lee JG, Kim KS et al. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection. Hepatogastroenterology 55(88), 2140-2145 (2008).
5. Kayahara M, Nagakawa T, Nakagawara H, Kitagawa H, Ohta T. Prognostic factors for gallbladder cancer in Japan. Ann. Surg. 248(5), 807-814 (2008).
6. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann. Surg. 245(5), 717-725 (2007).
7. Dobbin K, Simon R. Sample size determination in microarray experiments for class comparison and prognostic classifcation. Biostatistics 6(1), 27-38 (2005).
8. Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLoS ONE 3(11), E3661 (2008).
9. Ioannidis JP, Allison DB, Ball CA et al. Repeatability of published microarray gene expression analyses. Nat. Genet. 41(2), 149-155 (2009).
10. Omenn GS, States DJ, Adamski M et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5(13), 3226-3245 (2005).
11. Gong Y, Li X, Yang B et al. Different immunoaffnity fractionation strategies to characterize the human plasma proteome. J. Proteome Res. 5(6), 1379-1387 (2006).
12. Anderson NL, Polanski M, Pieper R et al. The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol. Cell. Proteomics 3(4), 311-326 (2004).
13. Service RF. Proteomics. Proteomics ponders prime time. Science 321(5897), 1758-1761 (2008).
14. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250(10), 4007-4021 (1975).
15. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26(3), 231-243 (1975).
16. Strahler JR, Hanash SM, Somerlot L, Weser J, Postel W, Gorg A. High resolution two-dimensional polyacrylamide gel electrophoresis of basic myeloid polypeptides: use of immobilized pH gradients in the frst dimension. Electrophoresis 8(4), 165-173 (1987).
17. Righetti PG. Immobilized pH Gradients: Theory and Methodology. Burdon RH, van Knippenberg PH (Eds). Elsevier, Amsterdam, The Netherlands (1990).
18. Sabounchi-Schutt F, Astrom J, Olsson I, Eklund A, Grunewald J, Bjellqvist B. An immobiline DryStrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis 21(17), 3649-3656 (2000).
19. Sanchez JC, Rouge V, Pisteur M et al Improved and simplifed in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 18(3-4), 324-327 (1997).
20. Gorg A, Obermaier C, Boguth G, Weiss W Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: wide pH gradients up to pH 12, longer separation distances and simplifed procedures. Electrophoresis 20 (4-5), 712-717 (1999).
21. Gelf C, Morelli A, Rovida E, Righetti PG. pH measurements in ultranarrow immobilized pH gradients. J. Biochem. Biophys. Methods 13(2), 113-124 (1986).
22. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18(11), 2071-2077 (1997).
23. Kondo T, Hirohashi S. Application of highly sensitive fuorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc. 1(6), 2940-2956 (2007).
24. Shaw J, Rowlinson R, Nickson J et al. Evaluation of saturation labelling two-dimensional difference gel electrophoresis fuorescent dyes. Proteomics 3(7), 1181-1195 (2003).
25. Kondo T, Seike M, Mori Y, Fujii K, Yamada T, Hirohashi S. Application of sensitive fuorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics 3(9), 1758-1766 (2003).
26. Rabilloud T Use of thiourea to increase the solubility of membrane proteins in two-dimensional electrophoresis. Electrophoresis 19(5), 758-760 (1998). (Pubitemid 28236679)
27. Taylor RS, Wu CC, Hays LG, Eng JK, Yates JR 3rd, Howell KE. Proteomics of rat liver Golgi complex: minor proteins are identifed through sequential fractionation. Electrophoresis 21(16), 3441-3459 (2000).
28. Westbrook JA, Yan JX, Wait R, Welson SY, Dunn MJ. Zooming-in on the proteome: very narrow-range immobilised pH gradients reveal more protein species and isoforms. Electrophoresis 22(14), 2865-2871 (2001).
29. Poland J, Cahill MA, Sinha P. Isoelectric focusing in long immobilized pH gradient gels to improve protein separation in proteomic analysis. Electrophoresis 24(7-8), 1271-1275 (2003).
30. Zhan X, Desiderio DM. A reference map of a human pituitary adenoma proteome. Proteomics 3(5), 699-713 (2003). (Pubitemid 36570260)
31. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771(1-2), 303-328 (2002).
32. Cho SY, Park KS, Shim JE et al. An integrated proteome database for two-dimensional electrophoresis data analysis and laboratory information management system. Proteomics 2(9), 1104-1113 (2002).
33. Fujii K, Kondo T, Yokoo H et al. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. Proteomics 6(5), 1640-1653 (2006).
34. Li F, Xiao Z, Zhang P et al. A reference map of human nasopharyngeal squamous carcinoma proteome. Int. J. Oncol. 30(5), 1077-1088 (2007).
35. Li F, Li M, Xiao Z, Zhang P, Li J, Chen Z. Construction of a nasopharyngeal carcinoma 2D/MS repository with open source XML database-Xindice. BMC Bioinformatics 7, 13 (2006).
36. Oh JM, Brichory F, Puravs E et al. A database of protein expression in lung cancer. Proteomics 1(10), 1303-1319 (2001).
37. Mori Y, Kondo T, Yamada T, Tsuchida A, Aoki T, Hirohashi S. Two-dimensional electrophoresis database of fuorescence-labeled proteins of colon cancer cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 823(2), 82-97 (2005).
38. Hanash SM, Teichroew D. Mining the human proteome: experience with the human lymphoid protein database. Electrophoresis 19(11), 2004-2009 (1998).
39. Traxler E, Bayer E, Stockl J, Mohr T, Lenz C, Gerner C. Towards a standardized human proteome database: quantitative proteome profling of living cells. Proteomics 4(5), 1314-1323 (2004).
40. Fujii K, Kondo T, Yamada M, Iwatsuki K, Hirohashi S. Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2-D DIGE and MS. Proteomics 6(17), 4856-4876 (2006).
41. Chen G, Gharib TG, Huang CC et al. Discordant protein mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1(4), 304-313 (2002)
42. Nishizuka S, Charboneau L, Young L et al. Proteomic profling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA 100(24), 14229-14234 (2003).
43. Shankavaram UT, Reinhold WC, Nishizuka S et al. Transcript and protein expression profles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther. 6(3), 820-832 (2007).
44. Yamada M, Fujii K, Koyama K, Hirohashi S, Kondo T. The proteomic profle of pancreatic cancer cell lines corresponding to carcinogenesis and metastasis. J. Proteomics Bioinform. 2, 1-18 (2009).
45. Uemura N, Nakanishi Y, Kato H et al. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int. J. Cancer 124(9), 2106-2115 (2009).
46. Kikuta K, Tochigi N, Shimoda T et al. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics. Clin. Cancer Res. 15(8), 2885-2894 (2009).